Resource Logo
CDC HIV/AIDS/Viral Hepatitis/STD/TB Prevention News Update

GLOBAL: Poor Nations Seek New Hepatitis Drug




 

New York Times (02.10.2014)

The New York Times reported that while the US Food and Drug Administration approved sofosbuvir—a new, simple medication regimen that cures hepatitis C—in December, it is expensive and will not be available to poorer countries. Manufactured by Gilead Sciences and sold under the name Sovaldi in the United States, it is expected to cost $84,000 per treatment. Four other companies are developing similar drugs that also will carry high price tags. The Access Campaign of Doctors Without Borders estimates that drug manufacturers can create cocktails of sofosbuvir and similar drugs for $250 or less, and according to Campaign Policy Chief Rohit Malpani, it is lobbying to make that possible. The campaign is opposing Gilead’s efforts to patent sofosbuvir in India, where the manufacturer hopes to license Indian drug companies to make a $2,000-per-treatment version. If prices become affordable, the Access Campaign plans to ask the Global Fund to Fight AIDS, Tuberculosis, and Malaria; the President’s Emergency Plan for AIDS Relief; and Unitaid to pay for the hepatitis drugs so that Doctors Without Borders can begin pilot treatment programs in several countries.



 


Copyright © 2014 -CDC Prevention News Update, Publisher. All rights reserved to Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.



Information in this article was accurate in February 12, 2014. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.